Maass T, Sfakianakis I, Staib F, Krupp M, Galle PR, Teufel A. Microarray-based gene expression analysis of hepatocellular carcinoma. Curr Genomics. 2010;11:261–8. doi:10.2174/138920210791233063.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet. 2012;44:760–4. doi:http://www.nature.com/ng/journal/v44/n7/abs/ng.2291.html#supplementary-information.
Article
CAS
PubMed
Google Scholar
Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533–43. doi:10.1016/s1470-2045(01)00486-7.
Article
CAS
PubMed
Google Scholar
Asia–Pacific Working Party on Prevention of Hepatocellular C. Prevention of hepatocellular carcinoma in the Asia–Pacific region: Consensus statements. J Gastroenterol Hepatol. 2010;25:657–63. doi:10.1111/j.1440-1746.2009.06167.x.
Article
Google Scholar
Venook AP, Papandreou C, Furuse J, Ladrón de Guevara L. The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective. Oncologist. 2010;15:5–13. doi:10.1634/theoncologist.2010-S4-05.
Article
PubMed
Google Scholar
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi:10.3322/caac.20107.
Article
PubMed
Google Scholar
Iavarone M, Colombo M. HBV-related HCC, clinical issues and therapy. Dig Liver Dis. 2011;43:S32–9.
Article
PubMed
Google Scholar
Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer. 1994;74:2442–8. doi:10.1002/1097-0142(19941101)74:9<2442::aid-cncr2820740909>3.0.co;2-#.
Article
PubMed
Google Scholar
Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol. 2001;28:441–9. doi:10.1016/s0093-7754(01)90137-x.
Article
CAS
PubMed
Google Scholar
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology. 2004;127:S35–50. doi:10.1053/j.gastro.2004.09.014.
Article
PubMed
Google Scholar
Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol. 2009;3:353–67. doi:10.1586/egh.09.35.
Article
PubMed
Google Scholar
Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol. 2005;40:225–35. doi:10.1007/s00535-005-1566-3.
Article
PubMed
Google Scholar
Yuen M-F, Hou J-L, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009;24:346–53. doi:10.1111/j.1440-1746.2009.05784.x.
Article
PubMed
Google Scholar
Merican I, Guan R, Amarapuka D, Alexander M, Chutaputti A, Chien R, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol. 2000;15:1356–61. doi:10.1046/j.1440-1746.2000.0150121356.x.
Article
CAS
PubMed
Google Scholar
Chen C-J, Wang L-Y, Yu M-W. Epidemiology of hepatitis B virus infection in the Asia–Pacific region. J Gastroenterol Hepatol. 2000;15:E3–6. doi:10.1046/j.1440-1746.2000.02124.x.
Article
PubMed
Google Scholar
Di Bisceglie AM. Hepatitis B and hepatocellular carcinoma. Hepatology. 2009;49:S56–60. doi:10.1002/hep.22962.
Article
PubMed
PubMed Central
Google Scholar
de Villa V, Lo CM. Liver Transplantation for Hepatocellular Carcinoma in Asia. Oncologist. 2007;12:1321–31. doi:10.1634/theoncologist.12-11-1321.
Article
PubMed
Google Scholar
Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology. 2004;127:S5–S16. doi:10.1053/j.gastro.2004.09.011.
Article
PubMed
Google Scholar
El-Serag HB. Hepatocellular Carcinoma: An Epidemiologic View. J Clin Gastroenterol. 2002;35:S72–8.
Article
PubMed
Google Scholar
Bridges JFP, Joy S, Gallego G, Kudo M, Ye S-L, Han K-H, et al. Needs for hepatocellular carcinoma control policy in the Asia-Pacific region. Asian Pac J Cancer Prev. 2011;12:2585–91.
PubMed
Google Scholar
Cabibbo G, Enea M, Attanasio M, Bruix J, Craxi A, Camma C. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology. 2010;51:1274–83. doi:10.1002/hep.23485.
Article
PubMed
Google Scholar
Cucchetti A, Piscaglia F, Cescon M, Ercolani G, Terzi E, Bolondi L, et al. Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Clin Cancer Res. 2012. doi:10.1158/1078-0432.ccr-11-2663.
PubMed
Google Scholar
Ho W-H, Lee K-T, Chen H-Y, Ho T-W, Chiu H-C. Disease-Free Survival after Hepatic Resection in Hepatocellular Carcinoma Patients: A Prediction Approach Using Artificial Neural Network. PLoS One. 2012;7:e29179. doi:10.1371/journal.pone.0029179.
Article
CAS
PubMed
PubMed Central
Google Scholar
Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study. Hepatology. 1997;25:1485–9. doi:10.1002/hep.510250629.
Article
CAS
PubMed
Google Scholar
Lee PH, Lin WJ, Tsang YM, Hu RH, Sheu JC, Lai MY, et al. Clinical management of recurrent hepatocellular carcinoma. Ann Surg. 1995;222:670–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, et al. Surgical Treatment for Liver Cancer. Dig Surg. 2007;24:120–5.
Article
PubMed
Google Scholar
Takayama T. Surgical Treatment for Hepatocellular Carcinoma. Jpn J Clin Oncol. 2011;41:447–54. doi:10.1093/jjco/hyr016.
Article
PubMed
Google Scholar
Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut. 2003;52:iii1–8. doi:10.1136/gut.52.suppl_3.iii1.
Article
PubMed
PubMed Central
Google Scholar
Deshpande R, Reilly D, Sherlock D. Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC. J Hepatol. 2011;2011. doi:10.4061/2011/686074.
Feng YX, Wang T, Deng YZ, Yang P, Li JJ, Guan DX, et al. Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model. Hepatology. 2011;53:483–92. doi:10.1002/hep.24075.
Article
CAS
PubMed
Google Scholar
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J-F, et al. Sorafenib in Advanced Hepatocellular Carcinoma. N Engl J Med. 2008;359:378–90. doi:10.1056/NEJMoa0708857.
Article
CAS
PubMed
Google Scholar
Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer. 2001;84:1424–31. doi:10.1054/bjoc.2001.1796.
Article
CAS
PubMed
PubMed Central
Google Scholar
Borrell B. How accurate are cancer cell lines? Nature. 2010;463:858. doi:10.1038/463858a.
Article
CAS
PubMed
Google Scholar
Leenders MW, Nijkamp MW, Borel Rinkes IH. Mouse models in liver cancer research: a review of current literature. World J Gastroenterol. 2008;14:6915–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sano D, Myers JN. Xenograft models of head and neck cancers. Head Neck Oncol. 2009;1:32. doi:10.1186/1758-3284-1-32.
Article
PubMed
PubMed Central
Google Scholar
Correia AL, Bissell MJ. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat. 2012;15:39–49. doi:10.1016/j.drup.2012.01.006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heijstek MW, Kranenburg O, Borel Rinkes IH. Mouse models of colorectal cancer and liver metastases. Dig Surg. 2005;22:16–25. doi:10.1159/000085342.
Article
CAS
PubMed
Google Scholar
Glazer ES, Stone EM, Zhu C, Massey KL, Hamir AN, Curley SA. Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts. Transl Oncol. 2011;4:138–46.
Article
PubMed
PubMed Central
Google Scholar
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249–64. doi:10.1093/biostatistics/4.2.249.
Article
PubMed
Google Scholar
Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15.
Article
PubMed
PubMed Central
Google Scholar
Aparicio S, Hidalgo M, Kung AL. Examining the utility of patient-derived xenograft mouse models. Nat Rev Cancer. 2015;15:311–6. doi:10.1038/nrc3944.
Article
CAS
PubMed
Google Scholar
Kato S, Espinoza N, Lange S, Villalon M, Cuello M, Owen GI. Characterization and phenotypic variation with passage number of cultured human endometrial adenocarcinoma cells. Tissue Cell. 2008;40:95–102. doi:10.1016/j.tice.2007.09.007.
Article
CAS
PubMed
Google Scholar
Cree IA, Glaysher S, Harvey AL. Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue. Curr Opin Pharmacol. 2010;10:375–9. doi:10.1016/j.coph.2010.05.001.
Article
CAS
PubMed
Google Scholar
Wilmanns C, Fan D, O’Brian CA, Bucana CD, Fidler IJ. Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer. 1992;52:98–104.
Article
CAS
PubMed
Google Scholar
Kuo TH, Kubota T, Watanabe M, Furukawa T, Kase S, Tanino H, et al. Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Res. 1993;13:627–30.
CAS
PubMed
Google Scholar
Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature. 2001;411:375–9. doi:10.1038/35077241.
Article
CAS
PubMed
Google Scholar
Kubota T. Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation. J Cell Biochem. 1994;56:4–8. doi:10.1002/jcb.240560103.
Article
CAS
PubMed
Google Scholar